Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the page's content or formatting since the last version.
    Difference
    0.0%
    Check dated 2026-07-03T22:36:44.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays an updated software revision tag, changing from v3.6.0 to v3.6.2. This reflects a platform update rather than a change to the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-06-27T01:03:39.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now explicitly indicates that recruitment is closed and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study). A formatting update replaces the Interventions heading from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the revision tag from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T13:38:16.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, indicating the latest documentation update has been applied.
    Difference
    0.0%
    Check dated 2026-06-05T09:52:11.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The site update indicates a new software revision from v3.5.3 to v3.5.4, signaling an incremental platform upgrade. This change relates to the site’s underlying version and does not modify the visible content or features on the page.
    Difference
    0.0%
    Check dated 2026-05-15T03:22:08.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The site revision has been updated from v3.5.2 to v3.5.3, indicating a new software release. This backend update does not alter the visible study details content on the page.
    Difference
    0.0%
    Check dated 2026-04-30T17:36:14.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.